|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM374022933 |
| 003 |
DE-627 |
| 005 |
20241209232000.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240625s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2024.110292
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1626.xml
|
| 035 |
|
|
|a (DE-627)NLM374022933
|
| 035 |
|
|
|a (NLM)38914362
|
| 035 |
|
|
|a (PII)S1521-6616(24)00401-7
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Caballero-Oteyza, Andrés
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a OTULIN-related conditions
|b Report of a new case and review of the literature using GenIA
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 19.07.2024
|
| 500 |
|
|
|a Date Revised 09.12.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a UpdateOf: Res Sq. 2024 Mar 08:rs.3.rs-3950863. doi: 10.21203/rs.3.rs-3950863/v2. - PMID 38712244
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a OTULIN encodes an eponymous linear deubiquitinase (DUB) essential for controlling inflammation as a negative regulator of the canonical NF-κB signaling pathway via the regulation of M1-Ub dynamics. Biallelic loss-of-function (LOF) mutations in OTULIN cause an autosomal recessive condition named Otulin-Related Autoinflammatory Syndrome (ORAS), also known as Otulipenia or AutoInflammation, Panniculitis, and Dermatosis Syndrome (AIPDS). Monoallelic OTULIN LOF, also known as OTULIN Haploinsufficiency (OHI) or Immunodeficiency 107 (IMD107), has been linked to an incompletely penetrant, dominantly inherited susceptibility to invasive Staphylococcal infections. At the same time, a recent novel ORAS-like inflammatory syndrome was described in association with a heterozygous missense mutation that appears to exert dominant negative (DN) effects. In this manuscript, we report the identification of a novel homozygous missense mutation, c.595 T > A; p.(Trp199Arg), in a Moroccan infant with an ORAS phenotype and provide experimental evidence for its pathogenicity. We go on to systematically review the literature for OTULIN-associated conditions by using the GenIA database (www.geniadb.net) to collect, extract and harmonize all clinical, laboratory and functional data for published patients and variants. Our comprehensive synthesis of genotypic, phenotypic, and mechanistic data enables a more in-depth view of the diverse mechanisms and pathways by which the OTULIN pathogenic variants may lead to human immune disease. This review may help variant classification activities and inform future variant evaluation, as well as the development of diagnostic and management guidelines. It also identifies current knowledge gaps and raises additional questions warranting future investigation
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Autoinflammation
|
| 650 |
|
4 |
|a GenIA
|
| 650 |
|
4 |
|a Human genetics
|
| 650 |
|
4 |
|a IMD107
|
| 650 |
|
4 |
|a Immunodeficiency
|
| 650 |
|
4 |
|a NF-κB
|
| 650 |
|
4 |
|a ORAS
|
| 650 |
|
4 |
|a OTULIN
|
| 650 |
|
4 |
|a OTULIN haploinsufficiency
|
| 650 |
|
4 |
|a Systematic review
|
| 650 |
|
4 |
|a Ubiquitin
|
| 650 |
|
7 |
|a Endopeptidases
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.-
|2 NLM
|
| 650 |
|
7 |
|a OTULIN protein, human
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.-
|2 NLM
|
| 700 |
1 |
|
|a Crisponi, Laura
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Peng, Xiao P
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Hongying
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mrovecova, Pavla
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Olla, Stefania
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Siguri, Chiara
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Marnissi, Farida
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jouhadi, Zineb
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aksentijevich, Ivona
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Grimbacher, Bodo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Proietti, Michele
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 265(2024) vom: 01. Aug., Seite 110292
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:265
|g year:2024
|g day:01
|g month:08
|g pages:110292
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2024.110292
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 265
|j 2024
|b 01
|c 08
|h 110292
|